Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New data on fructose-sweetened beverages and hepatic metabolism

16.03.2007
According to figures published by the World Health Organitzation (WHO), in the year 2015 some 2.3 bn adults will be overweight and more than 700 million will suffer from obesity, a pathology which is increasingly being seen in children.

In addition, for some time now the high incidence of obesity in developed countries has coincided with an increase in the consumption of beverages sweetened with fructose, a powerful sweetener. A team from the University of Barcelona (UB) has recently published a study in the journal Hepatology which provides clues to the molecular mechanism through which the fructose in beverages may alter lipid energy metabolism and cause fatty liver and metabolic syndrome.

The study was led by Dr Juan Carlos Laguna of the Department of Pharmacology and Therapeutic Chemistry at the Faculty of Pharmacy, who is also the director of the research group “Nuclear receptors regulating energy metabolism as pharmacological targets”, with the participation of Núria Roglans, Laia Vilà, Mireia Farré, Marta Alegret, Rosa Mª Sánchez and Manuel Vázquez-Carrera.

This preclinical study published in Hepatology was carried out with laboratory rats receiving fructose- or glucose-sweetened liquid intake. No solid food was given. “The fructose in fruit has nothing to do with this study,” stresses Professor Laguna. “Fruit is healthy and its consumption is strongly recommended. Our study focuses on liquid fructose intake as an addition to the ordinary diet.”

Fructose is mainly metabolized in the liver, the target organ of the metabolic alterations caused by the consumption of this sugar. In this study, rats receiving fructose-containing beverages presented a pathology similar to metabolic syndrome, which in the short term causes lipid accumulation (hypertriglyceridemia) and fatty liver, and at later stages hypertension, resistance to insulin, diabetes and obesity.

The fructose used to sweeten beverages alters the lipid metabolism in the liver and, according to the authors, represents a calorie overload to which the body’s metabolism is unable to adapt. Specifically, fructose increases fat synthesis in the liver and reduces its degradation through action on a specific nuclear receptor (PPARa), which controls fatty acid ß-oxidation. “The most novel finding,” says Laguna, “is that this molecular mechanism is related to an impairment in the leptin signal. Leptin is a hormone that plays a key role in the body’s energy control; among its peripheral actions, it accelerates fat oxidation in the liver and reduces its synthesis.”

The study shows that rats receiving beverages with fructose have an excess of leptin in blood. Curiously, though, the liver does not show the effects that one would expect in the presence of high levels of this hormone. It seems that the deficit in the degradation of the fatty acids in the liver may be related to the leptin resistance, which affects a transcription factor (Stat-3) involved in the signalling pathway of leptin in the liver and the hypothalamus. Nor were significant weight differences found between the rats drinking liquids with glucose or fructose, “possibly because this was a short-term experiment and there was no time to detect such changes,” notes Professor Laguna.

Poorly balanced diets and the lack of physical exercise are key factors in the increase of obesity and other metabolic diseases in modern societies. In epidemiological studies in humans, the effect of the intake of fructose-sweetened beverages seems to be more intense in women. Professor Laguna’s team intends to continue research on a variety of fronts: the study of the difference in response between sexes; the study of the molecular mechanisms of leptin resistance in the liver in rat models; experimental studies with hepatocyte cell cultures, and, further into the future, pilot studies of a fructose-rich diet in humans to find possible markers of metabolic alterations in blood cells.

Rosa Martínez | alfa
Further information:
http://www.ub.edu

Further reports about: Fructose Laguna Leptin beverages liver metabolic metabolism molecular mechanism

More articles from Life Sciences:

nachricht Climate Impact Research in Hannover: Small Plants against Large Waves
17.08.2018 | Leibniz Universität Hannover

nachricht First transcription atlas of all wheat genes expands prospects for research and cultivation
17.08.2018 | Leibniz-Institut für Pflanzengenetik und Kulturpflanzenforschung

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Color effects from transparent 3D-printed nanostructures

New design tool automatically creates nanostructure 3D-print templates for user-given colors
Scientists present work at prestigious SIGGRAPH conference

Most of the objects we see are colored by pigments, but using pigments has disadvantages: such colors can fade, industrial pigments are often toxic, and...

Im Focus: Unraveling the nature of 'whistlers' from space in the lab

A new study sheds light on how ultralow frequency radio waves and plasmas interact

Scientists at the University of California, Los Angeles present new research on a curious cosmic phenomenon known as "whistlers" -- very low frequency packets...

Im Focus: New interactive machine learning tool makes car designs more aerodynamic

Scientists develop first tool to use machine learning methods to compute flow around interactively designable 3D objects. Tool will be presented at this year’s prestigious SIGGRAPH conference.

When engineers or designers want to test the aerodynamic properties of the newly designed shape of a car, airplane, or other object, they would normally model...

Im Focus: Robots as 'pump attendants': TU Graz develops robot-controlled rapid charging system for e-vehicles

Researchers from TU Graz and their industry partners have unveiled a world first: the prototype of a robot-controlled, high-speed combined charging system (CCS) for electric vehicles that enables series charging of cars in various parking positions.

Global demand for electric vehicles is forecast to rise sharply: by 2025, the number of new vehicle registrations is expected to reach 25 million per year....

Im Focus: The “TRiC” to folding actin

Proteins must be folded correctly to fulfill their molecular functions in cells. Molecular assistants called chaperones help proteins exploit their inbuilt folding potential and reach the correct three-dimensional structure. Researchers at the Max Planck Institute of Biochemistry (MPIB) have demonstrated that actin, the most abundant protein in higher developed cells, does not have the inbuilt potential to fold and instead requires special assistance to fold into its active state. The chaperone TRiC uses a previously undescribed mechanism to perform actin folding. The study was recently published in the journal Cell.

Actin is the most abundant protein in highly developed cells and has diverse functions in processes like cell stabilization, cell division and muscle...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

LaserForum 2018 deals with 3D production of components

17.08.2018 | Event News

Within reach of the Universe

08.08.2018 | Event News

A journey through the history of microscopy – new exhibition opens at the MDC

27.07.2018 | Event News

 
Latest News

Smallest transistor worldwide switches current with a single atom in solid electrolyte

17.08.2018 | Physics and Astronomy

Robots as Tools and Partners in Rehabilitation

17.08.2018 | Information Technology

Climate Impact Research in Hannover: Small Plants against Large Waves

17.08.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>